Selected research
Market Analysis & Forecast
Global Medical Device Validation Service Market Analysis and Forecast 2026-2032
Market perspective
The global Medical Device Validation Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Medical Device Validation Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Medical Device Validation Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Medical Device Validation Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Medical Device Validation Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Medical Device Validation Service include SGS, QuEST, Global Services, Intertek, Element Materials Technology, TÜV SÜD, NAMSA, Eurofins Scientific and Charles River, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Medical Device Validation Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Medical Device Validation Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Medical Device Validation Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Medical Device Validation Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Medical Device Validation Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Medical Device Validation Service revenue, projected growth trends, production technology, application and end-user industry.
Medical Device Validation Service Segment by Company
SGS
QuEST
Global Services
Intertek
Element Materials Technology
TÜV SÜD
NAMSA
Eurofins Scientific
Charles River
Sterling Medical Devices
Pacific Biolabs
Toxikon
Steris Laboratories
Europlaz
HIGHPOWER Validation Testing & Lab Services
Tata Elxsi
Onyx Healthcare
QAEC
Zener Engineering Services
Lucideon
Applus+ Laboratories
Patient Guard
Medical Engineering Technologies
Tentamus
Test Labs
Medical Device Validation Service Segment by Type
Process Validation
Equipment Validation
Software Validation
Design Validation
Compliance Validation
Others
Medical Device Validation Service Segment by Application
Medical Device Manufacturing
Pharmaceutical and Biotech Equipment
Healthcare IT and Software Devices
Clinical and Laboratory Equipment
Others
Medical Device Validation Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Device Validation Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medical Device Validation Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Device Validation Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Medical Device Validation Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Medical Device Validation Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Medical Device Validation Service revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
List of Tables
Table 1. Global Medical Device Validation Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032
Table 2. Process Validation Major Player
Table 3. Equipment Validation Major Player
Table 4. Software Validation Major Player
Table 5. Design Validation Major Player
Table 6. Compliance Validation Major Player
Table 7. Others Major Player
Table 8. Global Medical Device Validation Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032
Table 9. Medical Device Manufacturing Major Player
Table 10. Pharmaceutical and Biotech Equipment Major Player
Table 11. Healthcare IT and Software Devices Major Player
Table 12. Clinical and Laboratory Equipment Major Player
Table 13. Others Major Player
Table 14. Medical Device Validation Service Industry Trends
Table 15. Medical Device Validation Service Industry Drivers
Table 16. Medical Device Validation Service Industry Opportunities and Challenges
Table 17. Medical Device Validation Service Industry Restraints
Table 18. Global Medical Device Validation Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032
Table 19. Global Medical Device Validation Service Market Size by Region (2021-2026) & (US$ Million)
Table 20. Global Medical Device Validation Service Market Share by Region (2021-2026)
Table 21. Global Medical Device Validation Service Market Size by Region (2027-2032) & (US$ Million)
Table 22. Global Medical Device Validation Service Market Share by Region (2027-2032)
Table 23. Global Medical Device Validation Service Revenue by Players (US$ Million) & (2021-2026)
Table 24. Global Medical Device Validation Service Revenue Market Share by Players (2021-2026)
Table 25. Global Medical Device Validation Service Key Players Ranking, 2024 VS 2025 VS 2026
Table 26. Global Medical Device Validation Service Key Players Headquarters & Area Served
Table 27. Global Medical Device Validation Service Players, Product Type & Application
Table 28. Global Medical Device Validation Service Players Establishment Date
Table 29. Global Players Market Concentration Ratio (CR5 and HHI)
Table 30. Global Medical Device Validation Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 31. Global Medical Device Validation Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million)
Table 32. Global Medical Device Validation Service Revenue by Type (2021-2026) & (US$ Million)
Table 33. Global Medical Device Validation Service Revenue by Type (2027-2032) & (US$ Million)
Table 34. Global Medical Device Validation Service Revenue Market Share by Type (2021-2026)
Table 35. Global Medical Device Validation Service Revenue Market Share by Type (2027-2032)
Table 36. Global Medical Device Validation Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million)
Table 37. Global Medical Device Validation Service Revenue by Application (2021-2026) & (US$ Million)
Table 38. Global Medical Device Validation Service Revenue by Application (2027-2032) & (US$ Million)
Table 39. Global Medical Device Validation Service Revenue Market Share by Application (2021-2026)
Table 40. Global Medical Device Validation Service Revenue Market Share by Application (2027-2032)
Table 41. SGS Company Information
Table 42. SGS Business Overview
Table 43. SGS Medical Device Validation Service Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 44. SGS Medical Device Validation Service Product Portfolio
Table 45. SGS Recent Development
Table 46. QuEST Company Information
Table 47. QuEST Business Overview
Table 48. QuEST Medical Device Validation Service Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 49. QuEST Medical Device Validation Service Product Portfolio
Table 50. QuEST Recent Development
Table 51. Global Services Company Information
Table 52. Global Services Business Overview
Table 53. Global Services Medical Device Validation Service Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 54. Global Services Medical Device Validation Service Product Portfolio
Table 55. Global Services Recent Development
Table 56. Intertek Company Information
Table 57. Intertek Business Overview
Table 58. Intertek Medical Device Validation Service Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 59. Intertek Medical Device Validation Service Product Portfolio
Table 60. Intertek Recent Development
Table 61. Element Materials Technology Company Information
Table 62. Element Materials Technology Business Overview
Table 63. Element Materials Technology Medical Device Validation Service Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 64. Element Materials Technology Medical Device Validation Service Product Portfolio
Table 65. Element Materials Technology Recent Development
Table 66. TÜV SÜD Company Information
Table 67. TÜV SÜD Business Overview
Table 68. TÜV SÜD Medical Device Validation Service Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 69. TÜV SÜD Medical Device Validation Service Product Portfolio
Table 70. TÜV SÜD Recent Development
Table 71. NAMSA Company Information
Table 72. NAMSA Business Overview
Table 73. NAMSA Medical Device Validation Service Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 74. NAMSA Medical Device Validation Service Product Portfolio
Table 75. NAMSA Recent Development
Table 76. Eurofins Scientific Company Information
Table 77. Eurofins Scientific Business Overview
Table 78. Eurofins Scientific Medical Device Validation Service Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 79. Eurofins Scientific Medical Device Validation Service Product Portfolio
Table 80. Eurofins Scientific Recent Development
Table 81. Charles River Company Information
Table 82. Charles River Business Overview
Table 83. Charles River Medical Device Validation Service Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 84. Charles River Medical Device Validation Service Product Portfolio
Table 85. Charles River Recent Development
Table 86. Sterling Medical Devices Company Information
Table 87. Sterling Medical Devices Business Overview
Table 88. Sterling Medical Devices Medical Device Validation Service Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 89. Sterling Medical Devices Medical Device Validation Service Product Portfolio
Table 90. Sterling Medical Devices Recent Development
Table 91. Pacific Biolabs Company Information
Table 92. Pacific Biolabs Business Overview
Table 93. Pacific Biolabs Medical Device Validation Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 94. Pacific Biolabs Medical Device Validation Service Product Portfolio
Table 95. Pacific Biolabs Recent Development
Table 96. Toxikon Company Information
Table 97. Toxikon Business Overview
Table 98. Toxikon Medical Device Validation Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 99. Toxikon Medical Device Validation Service Product Portfolio
Table 100. Toxikon Recent Development
Table 101. Steris Laboratories Company Information
Table 102. Steris Laboratories Business Overview
Table 103. Steris Laboratories Medical Device Validation Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 104. Steris Laboratories Medical Device Validation Service Product Portfolio
Table 105. Steris Laboratories Recent Development
Table 106. Europlaz Company Information
Table 107. Europlaz Business Overview
Table 108. Europlaz Medical Device Validation Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 109. Europlaz Medical Device Validation Service Product Portfolio
Table 110. Europlaz Recent Development
Table 111. HIGHPOWER Validation Testing & Lab Services Company Information
Table 112. HIGHPOWER Validation Testing & Lab Services Business Overview
Table 113. HIGHPOWER Validation Testing & Lab Services Medical Device Validation Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 114. HIGHPOWER Validation Testing & Lab Services Medical Device Validation Service Product Portfolio
Table 115. HIGHPOWER Validation Testing & Lab Services Recent Development
Table 116. Tata Elxsi Company Information
Table 117. Tata Elxsi Business Overview
Table 118. Tata Elxsi Medical Device Validation Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 119. Tata Elxsi Medical Device Validation Service Product Portfolio
Table 120. Tata Elxsi Recent Development
Table 121. Onyx Healthcare Company Information
Table 122. Onyx Healthcare Business Overview
Table 123. Onyx Healthcare Medical Device Validation Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 124. Onyx Healthcare Medical Device Validation Service Product Portfolio
Table 125. Onyx Healthcare Recent Development
Table 126. QAEC Company Information
Table 127. QAEC Business Overview
Table 128. QAEC Medical Device Validation Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 129. QAEC Medical Device Validation Service Product Portfolio
Table 130. QAEC Recent Development
Table 131. Zener Engineering Services Company Information
Table 132. Zener Engineering Services Business Overview
Table 133. Zener Engineering Services Medical Device Validation Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 134. Zener Engineering Services Medical Device Validation Service Product Portfolio
Table 135. Zener Engineering Services Recent Development
Table 136. Lucideon Company Information
Table 137. Lucideon Business Overview
Table 138. Lucideon Medical Device Validation Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 139. Lucideon Medical Device Validation Service Product Portfolio
Table 140. Lucideon Recent Development
Table 141. Applus+ Laboratories Company Information
Table 142. Applus+ Laboratories Business Overview
Table 143. Applus+ Laboratories Medical Device Validation Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 144. Applus+ Laboratories Medical Device Validation Service Product Portfolio
Table 145. Applus+ Laboratories Recent Development
Table 146. Patient Guard Company Information
Table 147. Patient Guard Business Overview
Table 148. Patient Guard Medical Device Validation Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 149. Patient Guard Medical Device Validation Service Product Portfolio
Table 150. Patient Guard Recent Development
Table 151. Medical Engineering Technologies Company Information
Table 152. Medical Engineering Technologies Business Overview
Table 153. Medical Engineering Technologies Medical Device Validation Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 154. Medical Engineering Technologies Medical Device Validation Service Product Portfolio
Table 155. Medical Engineering Technologies Recent Development
Table 156. Tentamus Company Information
Table 157. Tentamus Business Overview
Table 158. Tentamus Medical Device Validation Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 159. Tentamus Medical Device Validation Service Product Portfolio
Table 160. Tentamus Recent Development
Table 161. Test Labs Company Information
Table 162. Test Labs Business Overview
Table 163. Test Labs Medical Device Validation Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 164. Test Labs Medical Device Validation Service Product Portfolio
Table 165. Test Labs Recent Development
Table 166. North America Medical Device Validation Service Revenue by Type (2021-2026) & (US$ Million)
Table 167. North America Medical Device Validation Service Revenue by Type (2027-2032) & (US$ Million)
Table 168. North America Medical Device Validation Service Revenue by Application (2021-2026) & (US$ Million)
Table 169. North America Medical Device Validation Service Revenue by Application (2027-2032) & (US$ Million)
Table 170. North America Medical Device Validation Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 171. North America Medical Device Validation Service Revenue by Country (2021-2026) & (US$ Million)
Table 172. North America Medical Device Validation Service Revenue by Country (US$ Million) & (2027-2032)
Table 173. Europe Medical Device Validation Service Revenue by Type (2021-2026) & (US$ Million)
Table 174. Europe Medical Device Validation Service Revenue by Type (2027-2032) & (US$ Million)
Table 175. Europe Medical Device Validation Service Revenue by Application (2021-2026) & (US$ Million)
Table 176. Europe Medical Device Validation Service Revenue by Application (2027-2032) & (US$ Million)
Table 177. Europe Medical Device Validation Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 178. Europe Medical Device Validation Service Revenue by Country (2021-2026) & (US$ Million)
Table 179. Europe Medical Device Validation Service Revenue by Country (US$ Million) & (2027-2032)
Table 180. China Medical Device Validation Service Revenue by Type (2021-2026) & (US$ Million)
Table 181. China Medical Device Validation Service Revenue by Type (2027-2032) & (US$ Million)
Table 182. China Medical Device Validation Service Revenue by Application (2021-2026) & (US$ Million)
Table 183. China Medical Device Validation Service Revenue by Application (2027-2032) & (US$ Million)
Table 184. Asia Medical Device Validation Service Revenue by Type (2021-2026) & (US$ Million)
Table 185. Asia Medical Device Validation Service Revenue by Type (2027-2032) & (US$ Million)
Table 186. Asia Medical Device Validation Service Revenue by Application (2021-2026) & (US$ Million)
Table 187. Asia Medical Device Validation Service Revenue by Application (2027-2032) & (US$ Million)
Table 188. Asia Medical Device Validation Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million)
Table 189. Asia Medical Device Validation Service Revenue by Region (US$ Million) & (2021-2026)
Table 190. Asia Medical Device Validation Service Revenue by Region (US$ Million) & (2027-2032)
Table 191. SAMEA Medical Device Validation Service Revenue by Type (2021-2026) & (US$ Million)
Table 192. SAMEA Medical Device Validation Service Revenue by Type (2027-2032) & (US$ Million)
Table 193. SAMEA Medical Device Validation Service Revenue by Application (2021-2026) & (US$ Million)
Table 194. SAMEA Medical Device Validation Service Revenue by Application (2027-2032) & (US$ Million)
Table 195. SAMEA Medical Device Validation Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 196. SAMEA Medical Device Validation Service Revenue by Country (2021-2026) & (US$ Million)
Table 197. SAMEA Medical Device Validation Service Revenue by Country (US$ Million) & (2027-2032)
Table 198. Research Programs/Design for This Report
Table 199. Authors List of This Report
Table 200. Secondary Sources
Table 201. Primary Sources
List of Figures
Figure 1. Medical Device Validation Service Image
Figure 2. Global Medical Device Validation Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global Medical Device Validation Service Market Size Share 2021 VS 2025 VS 2032
Figure 4. Process Validation Image
Figure 5. Equipment Validation Image
Figure 6. Software Validation Image
Figure 7. Design Validation Image
Figure 8. Compliance Validation Image
Figure 9. Others Image
Figure 10. Global Medical Device Validation Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032
Figure 11. Global Medical Device Validation Service Market Size Share 2021 VS 2025 VS 2032
Figure 12. Medical Device Manufacturing Image
Figure 13. Pharmaceutical and Biotech Equipment Image
Figure 14. Healthcare IT and Software Devices Image
Figure 15. Clinical and Laboratory Equipment Image
Figure 16. Others Image
Figure 17. Global Medical Device Validation Service Market Size (US$ Million) & (2021-2032)
Figure 18. Global Medical Device Validation Service Market Size, (US$ Million), 2021 VS 2025 VS 2032
Figure 19. Global Medical Device Validation Service Market Share by Region: 2021 VS 2025 VS 2032
Figure 20. Global Medical Device Validation Service Players Revenue Share Top 10 and Top 5 in 2025
Figure 21. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 22. Global Medical Device Validation Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 23. Global Medical Device Validation Service Revenue Market Share 2021 VS 2025 VS 2032
Figure 24. Global Medical Device Validation Service Revenue Market Share by Type (2021-2032)
Figure 25. Global Medical Device Validation Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 26. Global Medical Device Validation Service Revenue Market Share by Application (2021 VS 2025 VS 2032)
Figure 27. Global Medical Device Validation Service Revenue Market Share by Application (2021-2032)
Figure 28. North America Medical Device Validation Service Revenue YoY Growth (2021-2032) & (US$ Million)
Figure 29. North America Medical Device Validation Service Revenue Share by Type (2021-2032)
Figure 30. North America Medical Device Validation Service Revenue Share by Application (2021-2032)
Figure 31. North America Medical Device Validation Service Revenue Share by Country (2021-2032)
Figure 32. United States Medical Device Validation Service Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 33. Canada Medical Device Validation Service Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 34. Mexico Medical Device Validation Service Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 35. Europe Medical Device Validation Service Revenue YoY Growth (2021-2032) & (US$ Million)
Figure 36. Europe Medical Device Validation Service Revenue Share by Type (2021-2032)
Figure 37. Europe Medical Device Validation Service Revenue Share by Application (2021-2032)
Figure 38. Europe Medical Device Validation Service Revenue Share by Country (2021-2032)
Figure 39. Germany Medical Device Validation Service Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 40. France Medical Device Validation Service Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 41. U.K. Medical Device Validation Service Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 42. Italy Medical Device Validation Service Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 43. Spain Medical Device Validation Service Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 44. Russia Medical Device Validation Service Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 45. Netherlands Medical Device Validation Service Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 46. Nordic Countries Medical Device Validation Service Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 47. China Medical Device Validation Service Revenue YoY Growth (2021-2032) & (US$ Million)
Figure 48. China Medical Device Validation Service Revenue Share by Type (2021-2032)
Figure 49. China Medical Device Validation Service Revenue Share by Application (2021-2032)
Figure 50. Asia Medical Device Validation Service Revenue YoY Growth (2021-2032) & (US$ Million)
Figure 51. Asia Medical Device Validation Service Revenue Share by Type (2021-2032)
Figure 52. Asia Medical Device Validation Service Revenue Share by Application (2021-2032)
Figure 53. Asia Medical Device Validation Service Revenue Share by Region (2021-2032)
Figure 54. Japan Medical Device Validation Service Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 55. South Korea Medical Device Validation Service Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 56. India Medical Device Validation Service Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 57. Australia Medical Device Validation Service Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 58. Taiwan Medical Device Validation Service Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 59. Southeast Asia Medical Device Validation Service Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 60. SAMEA Medical Device Validation Service Revenue YoY Growth (2021-2032) & (US$ Million)
Figure 61. SAMEA Medical Device Validation Service Revenue Share by Type (2021-2032)
Figure 62. SAMEA Medical Device Validation Service Revenue Share by Application (2021-2032)
Figure 63. SAMEA Medical Device Validation Service Revenue Share by Country (2021-2032)
Figure 64. Brazil Medical Device Validation Service Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 65. Argentina Medical Device Validation Service Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 66. Chile Medical Device Validation Service Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 67. Colombia Medical Device Validation Service Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 68. Peru Medical Device Validation Service Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 69. Saudi Arabia Medical Device Validation Service Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 70. Israel Medical Device Validation Service Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 71. UAE Medical Device Validation Service Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 72. Turkey Medical Device Validation Service Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 73. Iran Medical Device Validation Service Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 74. Egypt Medical Device Validation Service Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 75. Years Considered
Figure 76. Research Process
Figure 77. Key Executives Interviewed
Scope & coverage.
Types
- Process Validation
- Equipment Validation
- Software Validation
- Design Validation
- Compliance Validation
- Others
Applications
- Medical Device Manufacturing
- Pharmaceutical and Biotech Equipment
- Healthcare IT and Software Devices
- Clinical and Laboratory Equipment
- Others
Companies covered
- SGS
- QuEST
- Global Services
- Intertek
- Element Materials Technology
- TÜV SÜD
- NAMSA
- Eurofins Scientific
- Charles River
- Sterling Medical Devices
- Pacific Biolabs
- Toxikon
- Steris Laboratories
- Europlaz
- HIGHPOWER Validation Testing & Lab Services
- Tata Elxsi
- Onyx Healthcare
- QAEC
- Zener Engineering Services
- Lucideon
- Applus+ Laboratories
- Patient Guard
- Medical Engineering Technologies
- Tentamus
- Test Labs
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Medical Device Validation Service Market by Type
- 1.2.1 Global Medical Device Validation Service Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Process Validation
- 1.2.3 Equipment Validation
- 1.2.4 Software Validation
- 1.2.5 Design Validation
- 1.2.6 Compliance Validation
- 1.2.7 Others
- 1.3 Medical Device Validation Service Market by Application
- 1.3.1 Global Medical Device Validation Service Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Medical Device Manufacturing
- 1.3.3 Pharmaceutical and Biotech Equipment
- 1.3.4 Healthcare IT and Software Devices
- 1.3.5 Clinical and Laboratory Equipment
- 1.3.6 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Medical Device Validation Service Market Dynamics
- 2.1 Medical Device Validation Service Industry Trends
- 2.2 Medical Device Validation Service Industry Drivers
- 2.3 Medical Device Validation Service Industry Opportunities and Challenges
- 2.4 Medical Device Validation Service Industry Restraints
3 Global Growth Perspective
- 3.1 Global Medical Device Validation Service Market Perspective (2021-2032)
- 3.2 Global Medical Device Validation Service Growth Trends by Region
- 3.2.1 Global Medical Device Validation Service Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Medical Device Validation Service Market Size by Region (2021-2026)
- 3.2.3 Global Medical Device Validation Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Medical Device Validation Service Revenue by Players
- 4.1.1 Global Medical Device Validation Service Revenue by Players (2021-2026)
- 4.1.2 Global Medical Device Validation Service Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Medical Device Validation Service Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Medical Device Validation Service Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Medical Device Validation Service Key Players Headquarters & Area Served
- 4.4 Global Medical Device Validation Service Players, Product Type & Application
- 4.5 Global Medical Device Validation Service Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Medical Device Validation Service Market CR5 and HHI
- 4.6.3 2025 Medical Device Validation Service Tier 1, Tier 2, and Tier 3
5 Medical Device Validation Service Market Size by Type
- 5.1 Global Medical Device Validation Service Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Medical Device Validation Service Revenue by Type (2021-2032)
- 5.3 Global Medical Device Validation Service Revenue Market Share by Type (2021-2032)
6 Medical Device Validation Service Market Size by Application
- 6.1 Global Medical Device Validation Service Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Medical Device Validation Service Revenue by Application (2021-2032)
- 6.3 Global Medical Device Validation Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 SGS
- 7.1.1 SGS Company Information
- 7.1.2 SGS Business Overview
- 7.1.3 SGS Medical Device Validation Service Revenue and Gross Margin (2021-2026)
- 7.1.4 SGS Medical Device Validation Service Product Portfolio
- 7.1.5 SGS Recent Developments
- 7.2 QuEST
- 7.2.1 QuEST Company Information
- 7.2.2 QuEST Business Overview
- 7.2.3 QuEST Medical Device Validation Service Revenue and Gross Margin (2021-2026)
- 7.2.4 QuEST Medical Device Validation Service Product Portfolio
- 7.2.5 QuEST Recent Developments
- 7.3 Global Services
- 7.3.1 Global Services Company Information
- 7.3.2 Global Services Business Overview
- 7.3.3 Global Services Medical Device Validation Service Revenue and Gross Margin (2021-2026)
- 7.3.4 Global Services Medical Device Validation Service Product Portfolio
- 7.3.5 Global Services Recent Developments
- 7.4 Intertek
- 7.4.1 Intertek Company Information
- 7.4.2 Intertek Business Overview
- 7.4.3 Intertek Medical Device Validation Service Revenue and Gross Margin (2021-2026)
- 7.4.4 Intertek Medical Device Validation Service Product Portfolio
- 7.4.5 Intertek Recent Developments
- 7.5 Element Materials Technology
- 7.5.1 Element Materials Technology Company Information
- 7.5.2 Element Materials Technology Business Overview
- 7.5.3 Element Materials Technology Medical Device Validation Service Revenue and Gross Margin (2021-2026)
- 7.5.4 Element Materials Technology Medical Device Validation Service Product Portfolio
- 7.5.5 Element Materials Technology Recent Developments
- 7.6 TÜV SÜD
- 7.6.1 TÜV SÜD Company Information
- 7.6.2 TÜV SÜD Business Overview
- 7.6.3 TÜV SÜD Medical Device Validation Service Revenue and Gross Margin (2021-2026)
- 7.6.4 TÜV SÜD Medical Device Validation Service Product Portfolio
- 7.6.5 TÜV SÜD Recent Developments
- 7.7 NAMSA
- 7.7.1 NAMSA Company Information
- 7.7.2 NAMSA Business Overview
- 7.7.3 NAMSA Medical Device Validation Service Revenue and Gross Margin (2021-2026)
- 7.7.4 NAMSA Medical Device Validation Service Product Portfolio
- 7.7.5 NAMSA Recent Developments
- 7.8 Eurofins Scientific
- 7.8.1 Eurofins Scientific Company Information
- 7.8.2 Eurofins Scientific Business Overview
- 7.8.3 Eurofins Scientific Medical Device Validation Service Revenue and Gross Margin (2021-2026)
- 7.8.4 Eurofins Scientific Medical Device Validation Service Product Portfolio
- 7.8.5 Eurofins Scientific Recent Developments
- 7.9 Charles River
- 7.9.1 Charles River Company Information
- 7.9.2 Charles River Business Overview
- 7.9.3 Charles River Medical Device Validation Service Revenue and Gross Margin (2021-2026)
- 7.9.4 Charles River Medical Device Validation Service Product Portfolio
- 7.9.5 Charles River Recent Developments
- 7.10 Sterling Medical Devices
- 7.10.1 Sterling Medical Devices Company Information
- 7.10.2 Sterling Medical Devices Business Overview
- 7.10.3 Sterling Medical Devices Medical Device Validation Service Revenue and Gross Margin (2021-2026)
- 7.10.4 Sterling Medical Devices Medical Device Validation Service Product Portfolio
- 7.10.5 Sterling Medical Devices Recent Developments
- 7.11 Pacific Biolabs
- 7.11.1 Pacific Biolabs Company Information
- 7.11.2 Pacific Biolabs Business Overview
- 7.11.3 Pacific Biolabs Medical Device Validation Service Revenue and Gross Margin (2021-2026)
- 7.11.4 Pacific Biolabs Medical Device Validation Service Product Portfolio
- 7.11.5 Pacific Biolabs Recent Developments
- 7.12 Toxikon
- 7.12.1 Toxikon Company Information
- 7.12.2 Toxikon Business Overview
- 7.12.3 Toxikon Medical Device Validation Service Revenue and Gross Margin (2021-2026)
- 7.12.4 Toxikon Medical Device Validation Service Product Portfolio
- 7.12.5 Toxikon Recent Developments
- 7.13 Steris Laboratories
- 7.13.1 Steris Laboratories Company Information
- 7.13.2 Steris Laboratories Business Overview
- 7.13.3 Steris Laboratories Medical Device Validation Service Revenue and Gross Margin (2021-2026)
- 7.13.4 Steris Laboratories Medical Device Validation Service Product Portfolio
- 7.13.5 Steris Laboratories Recent Developments
- 7.14 Europlaz
- 7.14.1 Europlaz Company Information
- 7.14.2 Europlaz Business Overview
- 7.14.3 Europlaz Medical Device Validation Service Revenue and Gross Margin (2021-2026)
- 7.14.4 Europlaz Medical Device Validation Service Product Portfolio
- 7.14.5 Europlaz Recent Developments
- 7.15 HIGHPOWER Validation Testing & Lab Services
- 7.15.1 HIGHPOWER Validation Testing & Lab Services Company Information
- 7.15.2 HIGHPOWER Validation Testing & Lab Services Business Overview
- 7.15.3 HIGHPOWER Validation Testing & Lab Services Medical Device Validation Service Revenue and Gross Margin (2021-2026)
- 7.15.4 HIGHPOWER Validation Testing & Lab Services Medical Device Validation Service Product Portfolio
- 7.15.5 HIGHPOWER Validation Testing & Lab Services Recent Developments
- 7.16 Tata Elxsi
- 7.16.1 Tata Elxsi Company Information
- 7.16.2 Tata Elxsi Business Overview
- 7.16.3 Tata Elxsi Medical Device Validation Service Revenue and Gross Margin (2021-2026)
- 7.16.4 Tata Elxsi Medical Device Validation Service Product Portfolio
- 7.16.5 Tata Elxsi Recent Developments
- 7.17 Onyx Healthcare
- 7.17.1 Onyx Healthcare Company Information
- 7.17.2 Onyx Healthcare Business Overview
- 7.17.3 Onyx Healthcare Medical Device Validation Service Revenue and Gross Margin (2021-2026)
- 7.17.4 Onyx Healthcare Medical Device Validation Service Product Portfolio
- 7.17.5 Onyx Healthcare Recent Developments
- 7.18 QAEC
- 7.18.1 QAEC Company Information
- 7.18.2 QAEC Business Overview
- 7.18.3 QAEC Medical Device Validation Service Revenue and Gross Margin (2021-2026)
- 7.18.4 QAEC Medical Device Validation Service Product Portfolio
- 7.18.5 QAEC Recent Developments
- 7.19 Zener Engineering Services
- 7.19.1 Zener Engineering Services Company Information
- 7.19.2 Zener Engineering Services Business Overview
- 7.19.3 Zener Engineering Services Medical Device Validation Service Revenue and Gross Margin (2021-2026)
- 7.19.4 Zener Engineering Services Medical Device Validation Service Product Portfolio
- 7.19.5 Zener Engineering Services Recent Developments
- 7.20 Lucideon
- 7.20.1 Lucideon Company Information
- 7.20.2 Lucideon Business Overview
- 7.20.3 Lucideon Medical Device Validation Service Revenue and Gross Margin (2021-2026)
- 7.20.4 Lucideon Medical Device Validation Service Product Portfolio
- 7.20.5 Lucideon Recent Developments
- 7.21 Applus+ Laboratories
- 7.21.1 Applus+ Laboratories Company Information
- 7.21.2 Applus+ Laboratories Business Overview
- 7.21.3 Applus+ Laboratories Medical Device Validation Service Revenue and Gross Margin (2021-2026)
- 7.21.4 Applus+ Laboratories Medical Device Validation Service Product Portfolio
- 7.21.5 Applus+ Laboratories Recent Developments
- 7.22 Patient Guard
- 7.22.1 Patient Guard Company Information
- 7.22.2 Patient Guard Business Overview
- 7.22.3 Patient Guard Medical Device Validation Service Revenue and Gross Margin (2021-2026)
- 7.22.4 Patient Guard Medical Device Validation Service Product Portfolio
- 7.22.5 Patient Guard Recent Developments
- 7.23 Medical Engineering Technologies
- 7.23.1 Medical Engineering Technologies Company Information
- 7.23.2 Medical Engineering Technologies Business Overview
- 7.23.3 Medical Engineering Technologies Medical Device Validation Service Revenue and Gross Margin (2021-2026)
- 7.23.4 Medical Engineering Technologies Medical Device Validation Service Product Portfolio
- 7.23.5 Medical Engineering Technologies Recent Developments
- 7.24 Tentamus
- 7.24.1 Tentamus Company Information
- 7.24.2 Tentamus Business Overview
- 7.24.3 Tentamus Medical Device Validation Service Revenue and Gross Margin (2021-2026)
- 7.24.4 Tentamus Medical Device Validation Service Product Portfolio
- 7.24.5 Tentamus Recent Developments
- 7.25 Test Labs
- 7.25.1 Test Labs Company Information
- 7.25.2 Test Labs Business Overview
- 7.25.3 Test Labs Medical Device Validation Service Revenue and Gross Margin (2021-2026)
- 7.25.4 Test Labs Medical Device Validation Service Product Portfolio
- 7.25.5 Test Labs Recent Developments
8 North America
- 8.1 North America Medical Device Validation Service Revenue (2021-2032)
- 8.2 North America Medical Device Validation Service Revenue by Type (2021-2032)
- 8.2.1 North America Medical Device Validation Service Revenue by Type (2021-2026)
- 8.2.2 North America Medical Device Validation Service Revenue by Type (2027-2032)
- 8.3 North America Medical Device Validation Service Revenue Share by Type (2021-2032)
- 8.4 North America Medical Device Validation Service Revenue by Application (2021-2032)
- 8.4.1 North America Medical Device Validation Service Revenue by Application (2021-2026)
- 8.4.2 North America Medical Device Validation Service Revenue by Application (2027-2032)
- 8.5 North America Medical Device Validation Service Revenue Share by Application (2021-2032)
- 8.6 North America Medical Device Validation Service Revenue by Country
- 8.6.1 North America Medical Device Validation Service Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Medical Device Validation Service Revenue by Country (2021-2026)
- 8.6.3 North America Medical Device Validation Service Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Medical Device Validation Service Revenue (2021-2032)
- 9.2 Europe Medical Device Validation Service Revenue by Type (2021-2032)
- 9.2.1 Europe Medical Device Validation Service Revenue by Type (2021-2026)
- 9.2.2 Europe Medical Device Validation Service Revenue by Type (2027-2032)
- 9.3 Europe Medical Device Validation Service Revenue Share by Type (2021-2032)
- 9.4 Europe Medical Device Validation Service Revenue by Application (2021-2032)
- 9.4.1 Europe Medical Device Validation Service Revenue by Application (2021-2026)
- 9.4.2 Europe Medical Device Validation Service Revenue by Application (2027-2032)
- 9.5 Europe Medical Device Validation Service Revenue Share by Application (2021-2032)
- 9.6 Europe Medical Device Validation Service Revenue by Country
- 9.6.1 Europe Medical Device Validation Service Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Medical Device Validation Service Revenue by Country (2021-2026)
- 9.6.3 Europe Medical Device Validation Service Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Medical Device Validation Service Revenue (2021-2032)
- 10.2 China Medical Device Validation Service Revenue by Type (2021-2032)
- 10.2.1 China Medical Device Validation Service Revenue by Type (2021-2026)
- 10.2.2 China Medical Device Validation Service Revenue by Type (2027-2032)
- 10.3 China Medical Device Validation Service Revenue Share by Type (2021-2032)
- 10.4 China Medical Device Validation Service Revenue by Application (2021-2032)
- 10.4.1 China Medical Device Validation Service Revenue by Application (2021-2026)
- 10.4.2 China Medical Device Validation Service Revenue by Application (2027-2032)
- 10.5 China Medical Device Validation Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Medical Device Validation Service Revenue (2021-2032)
- 11.2 Asia Medical Device Validation Service Revenue by Type (2021-2032)
- 11.2.1 Asia Medical Device Validation Service Revenue by Type (2021-2026)
- 11.2.2 Asia Medical Device Validation Service Revenue by Type (2027-2032)
- 11.3 Asia Medical Device Validation Service Revenue Share by Type (2021-2032)
- 11.4 Asia Medical Device Validation Service Revenue by Application (2021-2032)
- 11.4.1 Asia Medical Device Validation Service Revenue by Application (2021-2026)
- 11.4.2 Asia Medical Device Validation Service Revenue by Application (2027-2032)
- 11.5 Asia Medical Device Validation Service Revenue Share by Application (2021-2032)
- 11.6 Asia Medical Device Validation Service Revenue by Country
- 11.6.1 Asia Medical Device Validation Service Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Medical Device Validation Service Revenue by Country (2021-2026)
- 11.6.3 Asia Medical Device Validation Service Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Medical Device Validation Service Revenue (2021-2032)
- 12.2 SAMEA Medical Device Validation Service Revenue by Type (2021-2032)
- 12.2.1 SAMEA Medical Device Validation Service Revenue by Type (2021-2026)
- 12.2.2 SAMEA Medical Device Validation Service Revenue by Type (2027-2032)
- 12.3 SAMEA Medical Device Validation Service Revenue Share by Type (2021-2032)
- 12.4 SAMEA Medical Device Validation Service Revenue by Application (2021-2032)
- 12.4.1 SAMEA Medical Device Validation Service Revenue by Application (2021-2026)
- 12.4.2 SAMEA Medical Device Validation Service Revenue by Application (2027-2032)
- 12.5 SAMEA Medical Device Validation Service Revenue Share by Application (2021-2032)
- 12.6 SAMEA Medical Device Validation Service Revenue by Country
- 12.6.1 SAMEA Medical Device Validation Service Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Medical Device Validation Service Revenue by Country (2021-2026)
- 12.6.3 SAMEA Medical Device Validation Service Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$4,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst